4-fluoroglutamine and Liver-Neoplasms

4-fluoroglutamine has been researched along with Liver-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for 4-fluoroglutamine and Liver-Neoplasms

Article	Year
[ Molecular imaging, 2022, Volume: 2022 Quantitative. For this study, we used two transgenic mouse models of HCC induced by protooncogenes, MYC, and MET. Biochemical data have shown that tumors induced by MYC have increased levels of glutamine metabolism compared to those induced by MET. One-hour dynamic [. Influx rate constants were significantly higher for MYC tumors (. Higher influx rate constants corresponded to elevated levels of glutamine metabolism as determined by biochemical assays. The data showed that there is a distinctive difference in glutamine metabolism between MYC and MET tumors. Our study has demonstrated the potential of [ Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Glutamine; Liver Neoplasms; Mice; Mice, Transgenic; Positron-Emission Tomography	2022

Article

Year

Molecular imaging, 2022, Volume: 2022

Quantitative. For this study, we used two transgenic mouse models of HCC induced by protooncogenes, MYC, and MET. Biochemical data have shown that tumors induced by MYC have increased levels of glutamine metabolism compared to those induced by MET. One-hour dynamic [. Influx rate constants were significantly higher for MYC tumors (. Higher influx rate constants corresponded to elevated levels of glutamine metabolism as determined by biochemical assays. The data showed that there is a distinctive difference in glutamine metabolism between MYC and MET tumors. Our study has demonstrated the potential of [

Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Glutamine; Liver Neoplasms; Mice; Mice, Transgenic; Positron-Emission Tomography

2022